J Clin Oncol 35 (2): 141-148, 2017.[PUBMED Abstract] Cort√©s J, Kim SB, Chung WP, et al.: Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.
N Engl J Med 386 (12): 1143-1154, 2022.[PUBMED Abstract] Rugo HS, Im SA, Cardoso F, et al.: Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial.
J Clin Oncol 41 (2): 198-205, 2023.[PUBMED Abstract] Rugo HS, Im SA, Cardoso F, et al.: Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial.